TROXERUTINA NORMON 100 mg/ml SOLUCION ORAL EFG Spānija - spāņu - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

troxerutina normon 100 mg/ml solucion oral efg

laboratorios normon, s.a. - troxerutina - excipientes: sacarina sodica,sorbato potasico,parahidroxibenzoato de metilo,parahidroxibenzoato de propilo,propilenglicol - agentes estabilizadores de capilares - bioflavoniodes - troxerutina

TROXERUTINA PENSA 100 mg/ml SOLUCION ORAL EFG Spānija - spāņu - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

troxerutina pensa 100 mg/ml solucion oral efg

pensa pharma, s.a.u - troxerutina - excipientes: propilenglicol,parahidroxibenzoato de metilo,parahidroxibenzoato de propilo,sorbato potasico,sacarina sodica - agentes estabilizadores de capilares - bioflavoniodes - troxerutina

TROXERUTINA NORMON 1000 mg GRANULADO PARA SOLUCION ORAL Spānija - spāņu - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

troxerutina normon 1000 mg granulado para solucion oral

laboratorios normon, s.a. - troxerutina - excipientes: sacarina sodica,isomalta - agentes estabilizadores de capilares - bioflavoniodes - troxerutina

FLUOXETINA 20 mg CAPSULAS Venecuēla - spāņu - Instituto Nacional de Higiene

fluoxetina 20 mg capsulas

viskon, c.a. - fluoxetina (bajo la forma de fluoxetina clohidrato) - capsulas - 20 mg

FLUOXETINA 20 mg TABLETAS Venecuēla - spāņu - Instituto Nacional de Higiene

fluoxetina 20 mg tabletas

biosyntec, s.a. - fluoxetina (bajo la forma de clohidrato de fluoxetina) - tableta - 20 mg

doraQuest l.a. Gel Oral Peru - spāņu - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

doraquest l.a. gel oral

agrovet market animal health - doramectina - gel oral - doramectina 1.75 g;excipientes c.s.p , doramectina 1.75 g; excipientes c.s.p - antiparasitarios internos: gastrointestinales (nematodos), pulmonares – traqueales. antiparasitarios de uso externo: cutáneos (microfilarias, larvas, gusaneras, nuches), reguladores del crecimiento (larvas/huevos), piojos. - equinos - endectocida de amplio espectro y larga acción, efectivo en el control de parasitosis internas (nemátodes gastrointestinales y pulmonares) y externas como piojos y problemas de miasis en equinos. la fórmula especial de doraquest® l.a. le confiere un agradable sabor a manzana, lo que lo hace un gel muy palatable facilitando completamente la dosificación.

Rinvoq Eiropas Savienība - spāņu - EMA (European Medicines Agency)

rinvoq

abbvie deutschland gmbh & co. kg - upadacitinib - artritis, reumatoide - inmunosupresores - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

TRESUVI 1 MG/ML SOLUCION PARA PERFUSION EFG Spānija - spāņu - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

tresuvi 1 mg/ml solucion para perfusion efg

amomed pharma gmbh - treprostinilo - soluciÓn para perfusiÓn - 1 mg/ml inyectable perfusión 10 ml - treprostinilo 1 mg - treprostinilo

TRESUVI 5 MG/ML SOLUCION PARA PERFUSION EFG Spānija - spāņu - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

tresuvi 5 mg/ml solucion para perfusion efg

amomed pharma gmbh - treprostinilo - soluciÓn para perfusiÓn - 5 mg/ml inyectable perfusión 10 ml - treprostinilo 5 mg - treprostinilo

TRESUVI 10 MG/ML SOLUCION PARA PERFUSION EFG Spānija - spāņu - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

tresuvi 10 mg/ml solucion para perfusion efg

amomed pharma gmbh - treprostinilo - soluciÓn para perfusiÓn - 10 mg/ml inyectable perfusión 10 ml - treprostinilo 10 mg - treprostinilo